% Expired Patents = 60.0

EPO Patents = 2

Forward Citations = 61

Loading Chart...

10 inventors (with patents filed for the assignee):

Long Mao (4 out of 25 patents)

Soan Cheng (4 out of 31 patents)

Daniel D Comer (4 out of 5 patents)

4. Guity P Balow (4 out of 7 patents)

5. David Pleynet (4 out of 5 patents)

6. Gonul Velicelebi (1 out of 29 patents)

7. Kenneth Stauderman (1 out of 23 patents)

8. Steve V Wagner (1 out of 7 patents)

9. Maria Z Kounnas (1 out of 3 patents)

10. Elizabeth J Ackermann (1 out of 11 patents)

11. Elizabeth J Ackerman (0 patent)

5 patents: Sort by Forward Citations

1. 8871460 - Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor (2014-10-28),

2. 8119680 - α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom (2012-02-21),

3. 8017629 - Compounds and uses thereof in modulating amyloid β (2011-09-13),

4. 7799808 - α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom (2010-09-21),

5. 7781442 - Compounds and uses thereof in modulating amyloid beta (2010-08-24),

Company Overview

Neurogenetic Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for neurological disorders. Our focus is on leveraging genetic insights to create personalized medicine solutions for conditions such as Alzheimer's, Parkinson's, and rare genetic disorders. With a strong commitment to research and development, we aim to improve the lives of patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#10 in Del Mar, CA

#12,073 in California

#51,644 in US

Del Mar, CA, United States of America

Neurogenetic Pharmaceuticals, Inc.

Forward Citations = 61

10 inventors:

Long Mao (4 out of 25 patents)

Soan Cheng (4 out of 31 patents)

Daniel D Comer (4 out of 5 patents)

4. Guity P Balow (4 out of 7 patents)

5. David Pleynet (4 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neurogenetic Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/neurogenetic-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]